GLPG - Galapagos NV
NASDAQ
->
Healthcare
->
Biotechnology
Mechelen,
Belgium
Type: Equity
GLPG price evolution
GLPG
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $48.02 | |||
| Short term investments | ||||
| Net receivables | $65.89 | $73.04 | $67.58 | |
| Inventory | $73.98 | $55.6 | $48.87 | |
| Total current assets | $3861.59 | $3956.09 | $4032.15 | |
| Long term investments | ||||
| Property, plant & equipment | $126.32 | $136.8 | $134.73 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $4357.4 | $4451.34 | $4522.34 | |
| Current liabilities | ||||
| Accounts payable | $135.2 | $121.13 | $131.07 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $428.22 | $444.04 | $475.07 | |
| Long term debt | $4.94 | $8.47 | $9.21 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1561.83 | $1829.78 | $1938.39 | |
| Shareholders' equity | ||||
| Retained earnings | -$234.16 | -$408.17 | -$445.67 | |
| Other shareholder equity | -$1.2 | -$1.2 | -$1.31 | |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $71.8 | $458.12 | $2233.37 | $2135.19 |
| Short term investments | $2469.81 | |||
| Net receivables | $65.66 | $66.56 | $128.16 | $173.4 |
| Inventory | $73.98 | $52.92 | $20.57 | $0.35 |
| Total current assets | $3861.59 | $4236.85 | $4861.85 | $5369.35 |
| Long term investments | $8.95 | |||
| Property, plant & equipment | $126.32 | $154.25 | $137.51 | $103.38 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $397.96 | |||
| Total investments | ||||
| Total assets | $4357.4 | $4734.35 | $5193.16 | $5717.73 |
| Current liabilities | ||||
| Accounts payable | $134.65 | $148.68 | $137.42 | $171.32 |
| Deferred revenue | $506.22 | |||
| Short long term debt | ||||
| Total current liabilities | $428.22 | $522.54 | $566.47 | $635.27 |
| Long term debt | $4.94 | $14.69 | $19.66 | $23.04 |
| Total noncurrent liabilities | $2755.34 | |||
| Total debt | ||||
| Total liabilities | $1561.83 | $2208.32 | $2549.8 | $3047.38 |
| Shareholders' equity | ||||
| Retained earnings | -$234.16 | -$501.54 | -$367.2 | -$334.7 |
| Other shareholder equity | -$1.2 | -$1.59 | -$11.9 | -$76.6 |
| Total shareholder equity | $2643.36 | $2670.36 | ||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $287 | $136.34 | ||
| Cost of revenue | ||||
| Gross Profit | $130.64 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $375.26 | $160.88 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $9.61 | -$0.1 | ||
| Interest expense | $93.89 | $55.96 | ||
| Net income | ||||
| Net income | $211.7 | $25.83 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $287 | $552.13 | $484.85 | $530.26 |
| Cost of revenue | $493.34 | $523.67 | ||
| Gross Profit | $540.05 | -$8.49 | $6.59 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $210.85 | $185.22 | ||
| Total operating expenses | $375.26 | $780.87 | $650.44 | $708.89 |
| Operating income | -$165.6 | -$178.63 | ||
| Income from continuing operations | ||||
| EBIT | -$165.6 | -$178.63 | ||
| Income tax expense | $9.61 | $2.84 | $2.42 | $1.23 |
| Interest expense | $93.89 | $62.62 | -$8.8 | -$9.39 |
| Net income | ||||
| Net income | $211.7 | -$217.99 | -$103.23 | -$305.44 |
| Income (for common shares) | -$103.23 | -$305.44 | ||
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $71.19 | -$5.22 | -$187.76 | -$288.67 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$5 | -$3.81 | -$1.74 | -$0.19 |
| Effect of exchange rate | -$1.52 | -$0.61 | -$0.31 | -$0.25 |
| Change in cash and equivalents | -$341.31 | -$348.74 | -$410.09 | -$383.98 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | -$103.23 | -$305.44 | ||
| Operating activities | ||||
| Depreciation | $14.84 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$503.83 | -$427.34 | ||
| Investing activities | ||||
| Capital expenditures | -$54.2 | -$42.52 | ||
| Investments | $570.41 | $845.05 | ||
| Total cash flows from investing | $71.19 | -$1245.51 | $541.24 | $757.29 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$7.19 | -$6.25 | ||
| Total cash flows from financing | -$5 | -$1.49 | -$3.88 | $22.04 |
| Effect of exchange rate | -$1.52 | $22.29 | $56.76 | -$70.54 |
| Change in cash and equivalents | -$341.31 | -$1725.25 | $90.3 | $281.45 |
News
Fundamentals
| Market cap | $1.89B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 65.84M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 155.12% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 9.02 |
| Quick ratio | 8.84 |